Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

China National Biotec Group

http://www.cnbg.com.cn

Latest From China National Biotec Group

World First Or Beating The US? China Ups COVID-19 Vaccines Game

Touting its coronavirus vaccines as a "global public good", China is quietly preparing for the first general approvals and launches, possibly within weeks, developers say. But who will be first in line to receive them? And at what cost? Distribution and pricing are just some of the unanswered questions.

China Coronavirus COVID-19

How One China State-Owned Group Became A Behemoth, Powered By COVID-19

Already producing a broader range of biologics than any biotech firm in the world, from antibodies via plasma products to testing assays to vaccines, the state-owned China National Biotec Group is becoming even bigger with policy support and one surprising helper: the coronavirus pandemic. But might it face challenges from innovators and foreign firms in a changing environment?

Asia Pacific China

How One China State-Owned Group Became A Behemoth, Powered By COVID-19

Already producing a broader range of biologics than any biotech firm in the world, from antibodies via plasma products to testing assays to vaccines, the state-owned China National Biotec Group is becoming even bigger with policy support and one surprising helper: the coronavirus pandemic. But might it face challenges from innovators and foreign firms in a changing environment?

China Coronavirus COVID-19

China Regulatory Express: 100,000 Get Emergency Use COVID-19 Vaccines

Over 100,000 people in China have already been inoculated with Sinopharm's COVID-19 vaccine under an EUA. Meanwhile, the country's regulatory agency has conducted an internal audit of the vaccines oversight process, and is drawing up guidance on the use of real world evidence for pediatric drugs.

Coronavirus COVID-19 Vaccines
See All

Company Information

UsernamePublicRestriction

Register